Psychiatrists&rsquo; awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa

Psychiatrists&rsquo; awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa

Jos&eacute; Manuel Olivares,1 K&ouml;ksal Alptekin,2 Jean-Michel Azorin,3 Fernando Ca&ntilde;as,4 Vincent Dubois,5 Robin Emsley,6 Philip Gorwood,7 Peter M Haddad,8 Dieter Naber,9 George Papageorgiou,10 Miquel Roca,11 Pierre Thomas,12 Guadalupe Martinez,13 Andreas Schreiner141...

Full description

Bibliographic Details
Main Authors:	Olivares JM, Alptekin K, Azorin JM, Ca&ntilde;as F, Dubois V, Emsley R, Gorwood P, Haddad PM, Naber D, Papageorgiou G, Roca M, Thomas P, Martinez G, Schreiner A
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-01-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/psychiatristsrsquo-awareness-of-adherence-to-antipsychotic-medication--a12085

Similar Items

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey
by: Olivares JM, et al.
Published: (2013-08-01)

Discrepancy in Taiwanese psychiatrists’ preferences for long-acting injectable antipsychotics across facilities: a nationwide questionnaire survey
by: Liu CH, et al.
Published: (2018-02-01)

Factors Affecting Psychiatrists’ Prescription of Atypical Antipsychotics in Taiwan
by: Lee Yih Dar, et al.

Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective
by: Watanabe Y, et al.
Published: (2020-12-01)

Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
by: Haddad PM, et al.
Published: (2014-06-01)

The South African Society of Psychiatrists (SASOP) Treatment Guidlelines for Psychiatric Disorders
by: R Emsley, et al.
Published: (2013-08-01)

Psychiatrists’ Understanding and Management of Conversion Disorder: A Bi-National Survey and Comparison with Neurologists
by: Dent B, et al.
Published: (2020-08-01)

Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics
by: de Bartolomeis A, et al.
Published: (2016-01-01)

Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey
by: Nagai N, et al.
Published: (2020-03-01)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
by: Eduard Parellada, et al.
Published: (2012-01-01)

Patients’ experiences of long-acting injectable antipsychotics: a qualitative study
by: Chiu LL, et al.
Published: (2019-07-01)

Psychiatrist Dhirendranath
by: Ashish Srivastava
Published: (2016-01-01)

An online survey of Turkish psychiatrists’ attitudes about and experiences of adult attention deficit hyperactivity disorder in clinical practice
by: Altın M, et al.
Published: (2016-10-01)

Naive questions on consciousness from a psychiatrist to non-psychiatrists
by: Kaprinis George S
Published: (2008-04-01)

Cost-effectiveness of an atypical conventional antipsychotic in South Africa: An economic evaluation of quetiapine versus haloperidol in the treatment of patients partially responsive to previous antipsychotics
by: Robin Emsley, et al.
Published: (2004-10-01)

Second-generation antipsychotics - a panacea?
by: Paul D Carey, et al.
Published: (2004-12-01)

Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire
by: Blackwood C, et al.
Published: (2020-07-01)

Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics
by: Bernardo M, et al.
Published: (2011-12-01)

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
by: Zhang H, et al.
Published: (2019-07-01)

Antipsychotic agents: efficacy and safety in schizophrenia
by: de Ara&uacute;jo AN, et al.
Published: (2012-11-01)

Communication skills in Psychiatry: patients with schizophrenia assessing Psychiatrists
by: Adriana Ondina Pestana Santos
Published: (2019)

Schizophrenia: What Non-Psychiatrist Physicians Need to Know
by: Tiago Pinto Queirós, et al.
Published: (2019-02-01)

Burnout in Indian Psychiatrists
by: Poduri Gopala Sarma
Published: (2018-03-01)

Civil Liability for the psychiatrist
by: Doha Mohammed Saeed, et al.
Published: (2013-06-01)

Psychiatrist's Perspective: Invited Commentary on “Early Diagnosis and Intervention for Autism Spectrum Disorder: Need for Pediatrician-Child Psychiatrist Liaison”
by: Varghese P. Punnoose
Published: (2019-01-01)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
by: Martinez-Martin P, et al.
Published: (2019-04-01)

Referral and collaboration between South African psychiatrists and religious or spiritual advisers: Views from some psychiatrists
by: Albert Bernard-Repsold Janse van Rensburg, et al.
Published: (2014-07-01)

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression
by: Chekani F, et al.
Published: (2020-01-01)

Crohn’s disease in women
by: Plav&scaron;ić I, et al.
Published: (2013-10-01)

Differing mental health practice among general practitioners, private psychiatrists and public psychiatrists
by: Kovess V, et al.
Published: (2005-10-01)

Comparison of second generation antipsychotics: are there any differences in efficacy?
by: Papageorgiou George
Published: (2006-02-01)

Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
by: Norio Sugawara, et al.
Published: (2014-01-01)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
by: Xinhua&nbsp;S Ren, et al.
Published: (2009-09-01)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Correll Christoph, et al.
Published: (2005-05-01)

Psychiatrist in court: Indian scenario
by: Vinay Basavaraju, et al.
Published: (2019-01-01)

Organ transplant & the psychiatrist: An overview
by: B N Anil Kumar, et al.
Published: (2015-01-01)

Child abuse: the role of psychiatrists
by: Asiri Rodrigo, et al.
Published: (2015-12-01)

Point of view: the professional psychiatrist
by: R. Hanwella, et al.
Published: (2017-12-01)

Liddle’s syndrome mechanisms, diagnosis and management
by: Enslow BT, et al.
Published: (2019-09-01)

Infantile nystagmus: an optometrist’s perspective
by: Zahidi AA, et al.
Published: (2017-09-01)